CMPR vs CNMD
CMPR: Cimpress is a mass customization company that leverages a shared technology platform to deliver personalized marketing and business products to millions of customers globally. CNMD: CONMED provides a specialized portfolio of medical technology and surgical devices focused on minimally invasive orthopedic and general surgery procedures.
Side-by-side fundamentals
| Metric | CMPR | CNMD | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $57.02 | $44.29 | |
| Market cap as of 2026-10-26 (share count; price 2026-10-30) | $1.4B | $1.3B | |
| P/E as of 2026-10-30 | 16.87 | 18.38 | CMPR lower |
| Net margin | +2.6% | +3.4% | CNMD higher |
| Gross margin FY2025, SEC XBRL | n/a | +54.6% | |
| Operating margin | +6.7% | +7.5% | CNMD higher |
| ROE FY2025, SEC XBRL | n/a | +4.6% | |
| ROA | +4.4% | +2.0% | CMPR higher |
| Debt / equity filed borrowings incl. finance leases, balance sheet 2026-09-30 | n/a | 0.77 | |
| Revenue growth (YoY) | +9.8% | +5.2% | CMPR higher |
| Revenue CAGR (3y) SEC XBRL | +6.7% | +9.6% | CNMD higher |
| Dividend yield as of 2026-09-03 | n/a | 1.81% | |
| Dividend streak (yrs) SEC XBRL | 0 | 1 | CNMD higher |
| Beta as of 2026-09-03 | 1.01 | 0.89 | |
| 1-year return as of 2026-10-30 close | -23.1% | -0.4% | CNMD higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.